|
Home
|
E-Submission
|
Sitemap
|
Contact Us
|
HOME
ABOUT
Aims and Scope
About the Journal
Editorial Board
Management Team
Open Access
Best Practice
Subscription Information
Contact us
BROWSE ARTICLES
All issues
Current Issue
Accepted Manuscripts
Most Read Articles
Most Cited Articles
KJCO Search
Author Index
EDITORIAL POLICIES
Research and Publication Ethics
Advertising Policy
Data Sharing Policy
Archiving Policy
Crossmark Policy
FOR CONTRIBUTORS
Instructions for Authors
Checklist
Copyright Transfer Agreement
Conflict of Interest Form
E-Submission
KJCO Search
> BROWSE ARTICLES > KJCO Search
Clinical experience of immune checkpoint inhibitor for a metastatic jejunal cancer patient with a high tumor mutational burden and low expression of programmed death-ligand 1
Seo Ree Kim, Sang Hoon Chun, Ji Hyun Kim, Sang-Yeob Kim, Bo-In Lee, Chan Kwon Jung, Jin Hyoung Kang
Korean J Clin Oncol.
2020;16(1):57-62. Published online June 30, 2020 DOI:
https://doi.org/10.14216/kjco.20010
Expression and clinical significance of the securin in colorectal cancer
Jaehee Choi, Taesung Ahn, Dongjun Jeong, Hyungju Kim, Soyoung Park, Eungjin Shin, Ji Won Chung, Moon Soo Lee, Moo-Jun Baek
Korean J Clin Oncol.
2014;10(2):78-83. Published online December 31, 2014 DOI:
https://doi.org/10.14216/kjco.14015
5,10-Methylenetetrahydrofolate reductase 677C>T polymorphism and microsatellite
instability
in sporadic colorectal cancer
Su-kyung Kwon, Jong Woo Kim, Nam Keun Kim
Korean J Clin Oncol.
2013;9(2):80-86. Published online December 30, 2013 DOI:
https://doi.org/10.14216/kjco.13015
Cited By 2
1
|
> BROWSE ARTICLES > KJCO Search
